News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Conference News ACC 2024 ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI Yael L. Maxwell April 07, 2024
News Conference News ACC 2023 PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF Todd Neale March 06, 2023
News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
News Conference News ACC 2020 TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients Todd Neale March 31, 2020
News Conference News ACC 2020 PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years Michael O'Riordan March 30, 2020
News Conference News ACC 2019 INFINITY: Aggressive Blood Pressure Lowering May Slow Cerebrovascular Disease in Elderly L.A. McKeown March 21, 2019
News Opinion Editor's Corner ACC 2019 Live From New Orleans: Days 2 and 3 at ACC 2019 Shelley Wood March 18, 2019
News Conference News ACC 2018 Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Conference News ACC 2017 FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI Todd Neale March 18, 2017
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2015 Outcomes at 5 Years Reinforce Durability of Stenting for Unprotected Left Main Disease L.A. McKeown March 15, 2015
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012